Shapely Reviews
Insurance first, compounded fallback from $99/mo
IMPORTANT: GOV Health Report is NOT a government website. This is an independent review. Consult healthcare professionals before medical decisions.
Insurance copays typically ~$25/mo; compounded from $99/mo
Section 1: Executive Summary
Shapely is built around a two-track structure that few competitors match. Track one is insurance: Shapely navigates coverage on your behalf and says it works with the vast majority of insurers to get cost-effective access to Wegovy and Zepbound, with commercial-insurance copays typically landing around $25 per month. Track two is what happens when that fails — Shapely will help you access manufacturer self-pay programs like NovoCare and LillyDirect, or, if your provider judges it clinically appropriate, prescribe compounded medication at $99 per month for semaglutide and $166 per month for tirzepatide. You meet your provider over video, a dietitian is part of the care team, and labs are strongly recommended though not required, with a flat $75 lab option for uninsured patients.
Documented Strengths
5 Items- 1Navigates insurance on your behalf, with copays typically around $25/month for commercial plans
- 2Falls back to manufacturer self-pay programs or compounded medication if coverage fails
- 3Compounded pricing from $99/month semaglutide and $166/month tirzepatide
- 4Dietitian included in the care team
- 5Flat $75 lab option for uninsured patients
Noted Limitations
4 Items- 1A membership fee applies on top of insurance-covered visits
- 2Not available with Aetna or Cigna as primary insurance for its Scale offering
- 3Compounded medications are not FDA-approved
- 4Insurance outcomes vary widely by plan
Section 2: Medications Offered
Note: Medication availability may vary. Compounded medications are not FDA-approved. Always verify current offerings directly with the provider.
Section 3: How It Works
Check your coverage in about two minutes by telling Shapely about your insurance and goals
Meet your assigned provider over video to build a personalized care plan
Complete labs if needed — Shapely orders them or accepts results from the last six months
Shapely pursues insurance coverage; if that fails, it helps you access manufacturer self-pay or compounded options
Continue with ongoing support from your provider and dietitian, tracked in the Shapely app
Section 4: Eligibility Requirements
- Adults meeting clinical criteria for GLP-1 weight-management therapy
- Must be 18 years or older
- No contraindications to GLP-1 receptor agonists
- Not pregnant or breastfeeding
- Note: the Scale offering is not currently available with Aetna or Cigna as primary insurance
Important: Final eligibility is determined by a licensed healthcare provider after reviewing your complete medical history.
Section 5: Potential Side Effects
WARNING: This is not a complete list. Serious side effects may occur. Seek immediate medical attention if you experience severe symptoms. Consult your healthcare provider for complete safety information.
Section 6: Service Features
Insurance & Payment
Shapely navigates insurance on your behalf and states it can work with the vast majority of insurers to get cost-effective access to GLP-1 medications like Wegovy and Zepbound. For patients with commercial insurance, medication copays are typically $25 per month, though some plans run higher. Insurance covers visits with providers and dietitians, subject to copays, deductibles, and coinsurance — but a membership fee still applies for app access, chat, education, tracking, and concierge medication-locating support. Scale is not currently available with Aetna or Cigna as primary insurance.
Shipping Information
Fulfillment depends on the pathway. Insurance and manufacturer self-pay prescriptions route through pharmacies; compounded prescriptions are prepared by state-licensed compounding pharmacies. Shapely also offers concierge support locating medication at local pharmacies.
Customer Support
Chat with your Shapely team through the app, plus phone support at 424-600-8360 and email. Concierge support for locating medication at local pharmacies is included in the membership.
Cancellation Policy
Shapely does not publish detailed cancellation terms on its main pages. Confirm membership cancellation terms with support before enrolling.
Section 7: Additional Services
Section 8: Program Structure
Both. Shapely's primary track is FDA-approved brand-name medication through insurance or manufacturer self-pay programs. Compounded semaglutide and tirzepatide are offered as a self-pay fallback when a provider determines it is clinically appropriate. Shapely states plainly that compounded medications are not FDA-approved.
You connect over video with an assigned expert provider who personalizes your care plan, and a dietitian is part of the ongoing care team. Chat access to the Shapely team is included.
Recent labs are strongly recommended but not required before starting most weight-loss medications. Shapely will order labs for you or accept results completed within the prior six months. Labs are typically covered by insurance with a possible copay; uninsured patients can use a flat $75 lab option requiring a Labcorp draw.
Varies by pathway — retail or mail-order pharmacies for insurance and manufacturer self-pay, state-licensed compounding pharmacies for compounded prescriptions.
Determined by the pathway and prescription; typically monthly.
Section 9: Cost Breakdown
Yes. Even when insurance covers your visits, a membership fee applies covering the app, chat with your Shapely team, exclusive education, tracking tools, and concierge medication-locating support. Confirm the current fee before enrolling.
Varies by pathway. With commercial insurance, medication copays are typically $25 per month. On self-pay compounded, Shapely publishes pricing starting at $99/month for compounded semaglutide and $166/month for compounded tirzepatide. Manufacturer self-pay programs are priced by Novo Nordisk and Eli Lilly respectively.
Shapely does not publish a standing refund policy on its main pages. Confirm before enrolling.
Not explicitly published. Membership fees, visits, and prescriptions are commonly HSA/FSA eligible — confirm with your plan administrator.
Section 10: Documented Limitations
- Membership fee applies even when insurance covers your care
- Not available with Aetna or Cigna as primary insurance for Scale
- Compounded fallback is not FDA-approved
- Insurance outcomes are plan-dependent and not guaranteed
- Cancellation and refund terms are not published up front
Section 11: Alternatives to Consider
Section 12: Frequently Asked Questions
Does Shapely work with insurance?
Yes — that is its primary model. Shapely navigates insurance on your behalf and says it can work with the vast majority of insurers for cost-effective access to Wegovy and Zepbound. Commercial-insurance copays are typically around $25 per month.
What happens if my insurance denies coverage?
Shapely helps you access manufacturer self-pay programs — Wegovy through NovoCare, Zepbound through LillyDirect — and, if your provider judges it clinically appropriate, can prescribe compounded medication starting at $99/month for semaglutide and $166/month for tirzepatide.
Do I need labs before starting?
Recent labs are strongly recommended but not required. Shapely will order them or accept results from the prior six months. Uninsured patients can use a flat $75 lab option at Labcorp.
Is there a membership fee even with insurance?
Yes. Shapely is explicit that a membership fee still applies when you use insurance, covering the app, chat with your care team, education, tracking tools, and concierge medication-locating support.
Are there insurance plans Shapely cannot work with?
Shapely notes that Scale is not currently available with Aetna or Cigna as primary insurance.
Assessment Recommendation
Best suited for: People who want to try insurance coverage first but need a credible, affordable fallback if their plan says no
Medical Disclaimer
This assessment is for general informational purposes only and is not medical advice, a diagnosis, or a treatment recommendation. GOV Health Report is an independent publisher, is not affiliated with any government agency, and does not practice medicine or dispense medication. GLP-1 medications are prescription drugs with serious potential risks and are not appropriate for everyone. Only a licensed clinician who has evaluated you can determine whether treatment is safe for you. Compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality. Always talk to a qualified healthcare professional before starting, stopping, or changing any medication, and read our full medical disclaimer.
Date reviewed: August 5, 2026. Details on this page reflect information published by the provider as of that date and can change without notice.
Shapely
Insurance copays typically ~$25/mo; compounded from $99/mo
Quick Reference
Consumer Reviews
Public submissions and ratings
No ratings yet
Rate your experience
Click a star to submit your rating
Questions & Discussions
Community forum and inquiries
Proceed to Shapely
Assessment complete. Ready to start your consultation?
Visit ShapelyAffiliate link — Commission may be earned on sign-ups